{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:49:43Z","timestamp":1793713783381,"version":"4.6.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.neuropharm.2013.02.006","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T13:40:40Z","timestamp":1361194840000},"page":"254-260","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction"],"prefix":"10.1016","volume":"70","author":[{"given":"Christian","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Patte-Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Taleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Bourguignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Bihel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Maitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayikoe G.","family":"Mensah-Nyagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.02.006_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2131\/jts.37.139","article-title":"Protective effect of sulphoraphane against oxidative stress mediated toxicity induced by CuO nanoparticles in mouse embryonic fibroblasts BALB 3T3","volume":"37","author":"Akhtar","year":"2012","journal-title":"J.\u00a0Toxicol. Sci."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bcp.2012.07.030","article-title":"Kynurenic acid inhibits glutamatergic transmission to CA1 pyramidal neurons via alpha7 nAChR-dependent and -independent mechanisms","volume":"84","author":"Banerjee","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib3","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/sj.cdd.4402216","article-title":"Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis","volume":"14","author":"Benosman","year":"2007","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2002.00855.x","article-title":"Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?","volume":"81","author":"Carson","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.pharmtox.43.100901.135828","article-title":"Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals","volume":"43","author":"Denison","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","article-title":"Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling","volume":"115","author":"DiNatale","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brainres.2007.03.072","article-title":"Neprilysin protects neurons against Abeta peptide toxicity","volume":"1152","author":"El-Amouri","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00023210-200923020-00001","article-title":"Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders","volume":"23","author":"Erhardt","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2013.02.006_bib9","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.2174\/092986709789909602","article-title":"Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives","volume":"16","author":"Fulop","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib10","doi-asserted-by":"crossref","first-page":"e5099","DOI":"10.1371\/journal.pone.0005099","article-title":"A\u00a0PKC-dependent recruitment of MMP-2 controls semaphorin-3A growth-promoting effect in cortical dendrites","volume":"4","author":"Gonthier","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2013.02.006_bib11","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1111\/j.1582-4934.2010.01123.x","article-title":"Kynurenines, neurodegeneration and Alzheimer's disease","volume":"14","author":"Kincses","year":"2010","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0076-6879(95)48018-8","article-title":"Neprilysin: assay methods, purification, and characterization","volume":"248","author":"Li","year":"1995","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/NEN.0b013e3181afe475","article-title":"Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity","volume":"68","author":"Miners","year":"2009","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(99)00196-X","article-title":"Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites","volume":"375","author":"Moroni","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00702-011-0763-x","article-title":"Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery","volume":"119","author":"Moroni","year":"2012","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1471-4159.1988.tb04852.x","article-title":"Presence of kynurenic acid in the mammalian brain","volume":"51","author":"Moroni","year":"1988","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib17","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11064-009-0099-1","article-title":"Changes in extracellular kynurenic acid concentrations in rat prefrontal cortex after d-kynurenine infusion: an in\u00a0vivo microdialysis study","volume":"35","author":"Ogaya","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbrc.2007.10.197","article-title":"GPR35 is a functional receptor in rat dorsal root ganglion neurons","volume":"365","author":"Ohshiro","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-8993(02)02741-5","article-title":"In\u00a0vitro and in\u00a0vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site","volume":"944","author":"Ohtani","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0278-5846(99)00032-9","article-title":"Brain concentrations of kynurenic acid after a systemic neuroprotective dose in the gerbil model of global ischemia","volume":"23","author":"Salvati","year":"1999","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.02.006_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib23","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood.V78.7.1834.1834","article-title":"CD10 (CALLA)\/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation","volume":"78","author":"Shipp","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2013.02.006_bib24","doi-asserted-by":"crossref","first-page":"21895","DOI":"10.1074\/jbc.M008511200","article-title":"Neprilysin degrades both amyloid beta peptides 1\u201340 and 1\u201342 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases","volume":"276","author":"Shirotani","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-6147(00)01451-6","article-title":"Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection","volume":"21","author":"Stone","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-2999(02)01851-4","article-title":"The pharmacological manipulation of glutamate receptors and neuroprotection","volume":"447","author":"Stone","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0074-7742(07)82006-X","article-title":"New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection","volume":"82","author":"Turner","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2009.02.326","article-title":"The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection","volume":"283","author":"Vamos","year":"2009","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions. Nature reviews","volume":"12","author":"Vecsei","year":"2012","journal-title":"Drug Discov."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/nlme.1999.3947","article-title":"Glycine(B) receptor antagonists and partial agonists prevent memory deficits in inhibitory avoidance learning","volume":"74","author":"Viu","year":"2000","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib31","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib32","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1471-4159.2008.05855.x","article-title":"Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells","volume":"108","author":"Wang","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-4159.2010.06899.x","article-title":"Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain","volume":"115","author":"Wang","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib34","doi-asserted-by":"crossref","first-page":"e19229","DOI":"10.1371\/journal.pone.0019229","article-title":"Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2013.02.006_bib35","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00702-009-0263-4","article-title":"Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies","volume":"116","author":"Zadori","year":"2009","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2013.02.006_bib36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813000488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813000488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T08:28:42Z","timestamp":1595406522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813000488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":36,"alternative-id":["S0028390813000488"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.02.006","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}